Marseille researchers work towards personalised medicine for pancreatic cancer – News – CIVIS – Europe’s Civic University Alliance [Μετάβαση στο περιεχόμενο](#main) ![](https://civis.eu/build/assets/circle-07-COrlhHVd.svg) ![](https://civis.eu/build/assets/circle-01-CEiLnzkH.svg) ![](https://civis.eu/build/assets/circle-05-Dj7Wr3Es.svg) [ ![CIVIS – Europe’s Civic University Alliance](https://civis.eu/build/assets/civis-CCpvK1nT.svg)](https://civis.eu/el) - [ Ανακάλυψε ](https://civis.eu/el/discover-civis-alliance) - [ Τι είναι το CIVIS; ](https://civis.eu/el/discover-civis-alliance/what-is-civis) - [ Το έργο μας ](https://civis.eu/el/discover-civis-alliance/our-work) - [ Αποστολή, Όραμα & Αξίες ](https://civis.eu/el/discover-civis-alliance/our-institutional-journey) - [ Διακυβέρνηση & Διαχείριση ](https://civis.eu/el/discover-civis-alliance/governance-andamp-management) - [ Ποιος είναι Ποιος ](https://civis.eu/el/discover-civis-alliance/who-is-who) - [ CIVIS Association ](https://civis.eu/el/discover-civis-alliance/civis-association) [Ανοιχτά εργαστήρια & Συμμετοχή των πολιτών ](https://civis.eu/el/discover-civis-alliance/our-work/open-labs-civic-engagement) - [ Σπούδασε ](https://civis.eu/el/learn) - [ Μικτά Εντατικά προγράμματα ](https://civis.eu/el/learn/blended-intensive-programmes) - [ Ευέλικτη μάθηση ](https://civis.eu/el/learn/build-your-learning-path-with-our-modular-offer) - [ Μεταπτυχιακά προγράμματα ](https://civis.eu/el/learn/find-your-master-s-programme) - [ Εβδομάδες Κατάρτισης Προσωπικού & Παρακολούθηση Εργασίας ](https://civis.eu/el/learn/keep-on-learning-with-staff-weeks-andamp-job-shadowing) - [ Σπούδασε στο εξωτερικό ](https://civis.eu/el/learn/study-abroad-and-connect-with-civis-universities) [Discover the projects led by our students in 2025-2026 ](https://civis.eu/el/discover-civis-alliance/our-work/student-led-projects/discover-the-projects-led-by-our-students-in-2025-2026) [Μουσείο CIVIS Φόρουμ Πανεπιστημίων ](https://civis.eu/el/discover-civis-alliance/our-work/CIVIS-Museum-University-Forum) - [ Δίδαξε ](https://civis.eu/el/teach) - [ Προσκλήσεις υποβολής προτάσεων έργων ](https://civis.eu/el/teach/civis-calls) - [ Καινοτομήστε στη διδασκαλία σας ](https://civis.eu/el/teach/innovate-your-teaching) - [ Πόροι για εκπαιδευτικούς ](https://civis.eu/el/teach/resources-for-educators) [Μικτά Εντατικά Προγράμματα CIVIS: Ισχυρός Αντίκτυπος και Υψηλά Ποσοστά Ικανοποίησης, σύμφωνα με Νέα Έκθεση ](https://civis.eu/el/the-civis-newsroom/civis-bips-strong-impact-and-high-satisfaction-new-report-finds) [Musicians from all over CIVIS come together in Madrid to promote inclusiveness ](https://civis.eu/el/the-civis-newsroom/musicians-from-all-over-civis-come-together-in-madrid-to-promote-inclusiveness) - [ Κάνε έρευνα ](https://civis.eu/el/research) - [ Συνεργασία στην έρευνα ](https://civis.eu/el/research/research-collaboration) - [ Σταδιοδρομία, Δίκτυα & Κινητικότητα ](https://civis.eu/el/research/research-careers-networks-and-projects) - [ Πόροι για ερευνητές ](https://civis.eu/el/research/resources-for-researchers) [CIVIS launches new job space for early-stage researchers across Europe and Africa ](https://civis.eu/el/the-civis-newsroom/civis-launches-new-post-doc-doc-job-space-to-connect-early-stage-researchers-across-europe-and-africa) [Αντιμέτωποι με Κοινές Προκλήσεις, Διαμορφώνοντας Κοινές Λύσεις για την Αφρική και την Ευρώπη ](https://civis.eu/el/the-civis-newsroom/facing-common-challenges-shaping-joint-solutions-for-africa-and-europe) - [ Συνδέσου ](https://civis.eu/el/connect) - [ Ενημερωτικά Δελτία ](https://civis.eu/el/connect/newsletters) - [ Ημέρες CIVIS ](https://civis.eu/el/connect/civis-days) - [ Κοινωνία των Πολιτών ](https://civis.eu/el/discover-civis-alliance/our-work/open-labs-civic-engagement) - [ Επικοινωνήστε μαζί μας ](https://civis.eu/el/contact) - [ Τύπος και Επωνυμία ](https://civis.eu/el/connect/press-corner-branding-toolkit) [Ταράξτε τα νερά: Το CIVIS λανσάρει μια νέα σειρά Podcast ](https://civis.eu/el/the-civis-newsroom/make-some-waves-civis-launches-new-podcast-series) [Fake It Till You News It: Challenges and Solutions in Modern Media Student Innovation Forum ](https://civis.eu/el/discover-civis-alliance/our-work/student-led-projects/discover-the-projects-led-by-our-students-in-2025-2026/civis-creathon-contest) [ Ιστορίες ](https://civis.eu/el/the-civis-newsroom) el - [ en ](https://civis.eu/en/the-civis-newsroom/marseille-researchers-personalized-medicine-pancreatic-cancer) - [ de ](https://civis.eu/de/the-civis-newsroom/marseille-researchers-personalized-medicine-pancreatic-cancer) - [ fr ](https://civis.eu/fr/the-civis-newsroom/marseille-researchers-personalized-medicine-pancreatic-cancer) - [ it ](https://civis.eu/it/the-civis-newsroom/marseille-researchers-personalized-medicine-pancreatic-cancer) - [ es ](https://civis.eu/es/the-civis-newsroom/marseille-researchers-personalized-medicine-pancreatic-cancer) - [ sv ](https://civis.eu/sv/the-civis-newsroom/marseille-researchers-personalized-medicine-pancreatic-cancer) - [ ro ](https://civis.eu/ro/the-civis-newsroom/marseille-researchers-personalized-medicine-pancreatic-cancer) Menu - [Ανακάλυψε](https://civis.eu/el/discover-civis-alliance) [ Toggle submenu ](#primary-nav-sm-collapse-29) - [ Τι είναι το CIVIS; ](https://civis.eu/el/discover-civis-alliance/what-is-civis) - [ Το έργο μας ](https://civis.eu/el/discover-civis-alliance/our-work) - [ Αποστολή, Όραμα & Αξίες ](https://civis.eu/el/discover-civis-alliance/our-institutional-journey) - [ Διακυβέρνηση & Διαχείριση ](https://civis.eu/el/discover-civis-alliance/governance-andamp-management) - [ Ποιος είναι Ποιος ](https://civis.eu/el/discover-civis-alliance/who-is-who) - [ CIVIS Association ](https://civis.eu/el/discover-civis-alliance/civis-association) - [Σπούδασε](https://civis.eu/el/learn) [ Toggle submenu ](#primary-nav-sm-collapse-30) - [ Μικτά Εντατικά προγράμματα ](https://civis.eu/el/learn/blended-intensive-programmes) - [ Ευέλικτη μάθηση ](https://civis.eu/el/learn/build-your-learning-path-with-our-modular-offer) - [ Μεταπτυχιακά προγράμματα ](https://civis.eu/el/learn/find-your-master-s-programme) - [ Εβδομάδες Κατάρτισης Προσωπικού & Παρακολούθηση Εργασίας ](https://civis.eu/el/learn/keep-on-learning-with-staff-weeks-andamp-job-shadowing) - [ Σπούδασε στο εξωτερικό ](https://civis.eu/el/learn/study-abroad-and-connect-with-civis-universities) - [Δίδαξε](https://civis.eu/el/teach) [ Toggle submenu ](#primary-nav-sm-collapse-31) - [ Προσκλήσεις υποβολής προτάσεων έργων ](https://civis.eu/el/teach/civis-calls) - [ Καινοτομήστε στη διδασκαλία σας ](https://civis.eu/el/teach/innovate-your-teaching) - [ Πόροι για εκπαιδευτικούς ](https://civis.eu/el/teach/resources-for-educators) - [Κάνε έρευνα](https://civis.eu/el/research) [ Toggle submenu ](#primary-nav-sm-collapse-32) - [ Συνεργασία στην έρευνα ](https://civis.eu/el/research/research-collaboration) - [ Σταδιοδρομία, Δίκτυα & Κινητικότητα ](https://civis.eu/el/research/research-careers-networks-and-projects) - [ Πόροι για ερευνητές ](https://civis.eu/el/research/resources-for-researchers) - [Συνδέσου](https://civis.eu/el/connect) [ Toggle submenu ](#primary-nav-sm-collapse-33) - [ Ενημερωτικά Δελτία ](https://civis.eu/el/connect/newsletters) - [ Ημέρες CIVIS ](https://civis.eu/el/connect/civis-days) - [ Κοινωνία των Πολιτών ](https://civis.eu/el/discover-civis-alliance/our-work/open-labs-civic-engagement) - [ Επικοινωνήστε μαζί μας ](https://civis.eu/el/contact) - [ Τύπος και Επωνυμία ](https://civis.eu/el/connect/press-corner-branding-toolkit) [ Ιστορίες ](https://civis.eu/el/the-civis-newsroom) el - [ en ](https://civis.eu/en/the-civis-newsroom/marseille-researchers-personalized-medicine-pancreatic-cancer) - [ de ](https://civis.eu/de/the-civis-newsroom/marseille-researchers-personalized-medicine-pancreatic-cancer) - [ fr ](https://civis.eu/fr/the-civis-newsroom/marseille-researchers-personalized-medicine-pancreatic-cancer) - [ it ](https://civis.eu/it/the-civis-newsroom/marseille-researchers-personalized-medicine-pancreatic-cancer) - [ es ](https://civis.eu/es/the-civis-newsroom/marseille-researchers-personalized-medicine-pancreatic-cancer) - [ sv ](https://civis.eu/sv/the-civis-newsroom/marseille-researchers-personalized-medicine-pancreatic-cancer) - [ ro ](https://civis.eu/ro/the-civis-newsroom/marseille-researchers-personalized-medicine-pancreatic-cancer) 1. [The CIVIS Newsroom ](https://civis.eu/el/the-civis-newsroom) 2. Marseille researchers work towards personalised medicine for pancreatic cancer Marseille researchers work towards personalised medicine for pancreatic cancer ================================================================================ CIVIS Highlights 24 Ιουνίου 2024 Using a personalised treatment to fight pancreatic cancer may soon no longer be a fantasy. Researchers at the Cancer Research Center of Marseille and the Institut Paoli Calmettes carried out a molecular signature test on patients included in the French-Canadian PRODIGE-24/CCTG PA6 study. As a result, it is possible to predict the sensitivity of each patient to chemotherapy protocols and, therefore, to adapt each treatment. ![](/storage/files/national-cancer-institute-irmuwecjiz4-unsplash.jpg) **©** National Cancer Institute on Unsplash. In the management of pancreatic cancer, treatment with FOLFIRINOX chemotherapy, although effective, is associated with toxicity and reserved for patients who can tolerate this molecule. The choice of this chemotherapy is therefore currently based on the general health condition of patients, rather than on cancer biology. Researchers at the Cancer Research Center of Marseille (AMU/Inserm/CNRS/Institut Paoli Calmettes), in collaboration with clinicians at the Institut Paoli-Calmettes, have identified a signature based on the molecular characteristics of the tumour. With the help of artificial intelligence, this signature was also developed to be able to predict sensitivity to the various molecules used in pancreatic cancer. The beginning of a new era in pancreatic cancer management ---------------------------------------------------------- This *PancreasView* signature was tested for validation on 343 patients included in the PRODIGE-24/CCTG PA6 study, and with available biological material. The results showed that this signature made it possible to identify patients sensitive to the molecules under study. Patients who received appropriate therapy (m FOLFIRINOX or gemcitabine) showed improved survival. The use of these signatures in patient management could improve efficacy and reduce toxicity by avoiding unnecessary administration of drugs predicted to be ineffective. > *The results of this study underline the importance of the PancreasView molecular signature in identifying patients who respond favourably to treatment. This advance not only improves the survival of patients who receive appropriate therapy, but also considerably reduces the risk of associated toxicity. This breakthrough marks the beginning of a new era in pancreatic cancer management, where every patient can benefit from personalised treatment,"* says Dr. Nelson Dusetti, Inserm researcher at the Cancer Research Center of Marseille. About pancreatic cancer and the PRODIGE-24 study ------------------------------------------------ Pancreatic ductal adenocarcinoma, the most common form of pancreatic cancer, is a particularly aggressive disease, the incidence of which has been rising sharply in recent years. Surgery is currently the only chance of a cure, but is only possible in around 15% of patients, and metastatic relapse is unfortunately frequent. The use of adjuvant chemotherapy has significantly improved patient survival over the past 20 years. In 2018, the results of the PRODIGE-24/CCTG PA6 clinical trial, conducted in 493 patients in France and Canada, were presented. Promoted by Unicancer with the collaboration of the Canadian Cancer Trials Group (CCTG), and funded in France by the Ministry of Health and the Ligue Nationale Contre le Cancer, this study showed a significant improvement in survival, with median overall survival increasing from 3 years to 4.5 years in patients treated with mFOLFIRINOX (trichimiotherapy based on 5-fluorouracil, irinotecan and oxaliplatin) compared with gemcitabine alone. **Find out more about the study from the [original story, in French](https://infuse.univ-amu.fr/fr/decouvertes/vers-une-medecine-personnalisee-cancer-pancreas).** ### Other Highlights this month: - [“Eco-Emois”: a three-episode podcast produced by the ULB focuses on youthy and their feeling about the climate crisis](https://civis.eu/en/get-informed/news/eco-emois-ULB-podcast-youth-climate-crisis) - [The EC awards SUR's project exploring the consequences of marine plastic pollution on biodiversity](https://civis.eu/en/get-informed/news/ec-awards-SUR-consequences-marine-plastic-pollution-biodiversity) - [Two researchers from the University of Stockholm, leading a huge expedition in Greenland to study melting glaciers](https://civis.eu/en/get-informed/news/researchers-university-stockholm-lead-expedition-melting-glaciers) - [550 years since the first mention of the University of Tübingen](https://civis.eu/el/the-civis-newsroom#https://civis.eu/en/get-informed/news/550-years-since-the-first-mention-of-the-university-of-tubingen) Related news ------------ - [ ![](https://civis.eu/storage/files/post-it-risks-800x600.jpg?token=3f32ba7f3ab0220e88eeac41defdd8bf)Innovative micro-credential for professionals on AI for the workplace launched by CIVIS Learn 10 Φεβρουαρίου 2026 ](https://civis.eu/el/the-civis-newsroom/civis-micro-credentials-ai-and-work-supporting-teams-through-change) - [ ![](https://civis.eu/storage/files/pic-1-2-800x600.jpg?token=69133e274895176008d204580e76b040)Astronomers discover a superheated star factory in the early universe CIVIS Highlights 16 Δεκεμβρίου 2025 ](https://civis.eu/el/the-civis-newsroom/astronomers-discover-a-superheated-star-factory-in-the-early-universe) - [ ![](https://civis.eu/storage/files/amu-science-art-festiva-800x600.jpg?token=cde16a037d61b3a176432e0622b52977)The links between science and beliefs, debated at the amU' Science and Arts Festival 2025 CIVIS Highlights 26 Νοεμβρίου 2025 ](https://civis.eu/el/the-civis-newsroom/the-links-between-science-and-beliefs-debated-at-the-amu-science-and-arts-festival-2025) [Ανακαλύψτε όλες μας τις ιστορίες](https://civis.eu/el/the-civis-newsroom) [ PLUS researcher uncovers how earthquakes redefine river courses ](< https://civis.eu/el/the-civis-newsroom/plus-researcher-uncovers-how-earthquakes-redefine-river-courses >) [ “Eco-Emois” a ULB podcast focused on youth and the climate crisis ](< https://civis.eu/el/the-civis-newsroom/eco-emois-ULB-podcast-youth-climate-crisis >) ![CIVIS – Europe’s Civic University Alliance](https://civis.eu/build/assets/civis-CCpvK1nT.svg) ------------------------------------------------------------------------------------------------- Europe’s Civic University Alliance ![Co-funded by the European Union](https://civis.eu/build/assets/co-funded-by-the-european-union-DSKLW1us.png)Views and opinions expressed do not necessarily reflect those of the European Union or the European Education and Culture Executive Agency (EACEA). Neither can be held responsible for them. ### Άνθρωποι - [ Φοιτητές-/τριες ](https://civis.eu/el/i-am-a-student) - [ Ακαδημαϊκοί και ερευνητές ](https://civis.eu/el/i-am-an-academic-researcher) - [ Διοικητικοί ](https://civis.eu/el/i-am-an-administrator) - [ Κοινωνία των πολιτών ](https://civis.eu/el/discover-civis-alliance/our-work/open-labs-civic-engagement) - [ Τύπος ](https://civis.eu/el/connect/press-corner-branding-toolkit) ### Χρήσιμοι σύνδεσμοι - [ Πόροι ](https://civis.eu/el/resources) - [ Πλατφόρμα CIVIS Agora ](https://civis.eu/el/civis-agora-the-operational-hub-of-the-civis-digital-campus) - [ Πρωτοβουλία των Ευρωπαϊκών Πανεπιστημίων ](https://civis.eu/el/european-universities-initiative) - [ Προηγούμενες εκδηλώσεις ](https://civis.eu/el/past-events) - [ Επικοινωνία ](https://civis.eu/el/contact) [Newsletters](https://civis.eu/el/connect/newsletters) ### Social networks - [ ![](https://civis.eu/storage/files/instagram.svg) Instagram ](https://www.instagram.com/civis.eu/) - [ ![](https://civis.eu/storage/files/linkedin.svg) LinkedIn ](https://www.linkedin.com/company/civis-eu) - [ ![](https://civis.eu/storage/files/facebook.svg) Facebook ](https://www.facebook.com/CIVISEuropeanUniversity/) - [ ![](https://civis.eu/storage/files/youtube.svg) YouTube ](https://www.youtube.com/channel/UCdCm0FfreX81BuNH-znlRGQ) © 2026 – CIVIS – All rights reserved - [ Cookie Policy ](https://civis.eu/el/cookie-policy) - [ Privacy policy ](https://civis.eu/el/privacy-policy) Website by [Typi Design](https://typi.be) • Design by [Atelier Milky](https://ateliermilky.com) [ ](#top) Search